Tonneijck, L.

English

NARCIS 

Incretin-based drugs and the kidney in type 2 diabetes: Moving from safety to protection

VU Research Portal

VU Research PortalIncretin-based drugs and the kidney in type 2 diabetesTonneijck, L.2018document versionPublisher's PDF, also known as Version of recordLink to publication in VU Research Portalcitation for published version (APA)Tonneijck, L. (2018). Incretin-based drugs and the kidney in type 2 diabetes: Moving from safety to protection.General rightsCopyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright ownersand it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.            • You may not further distribute the material or use it for any profit-making activity or commercial gain            • You may freely distribute the URL identifying the publication in the public portal ?Take down policyIf you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediatelyand investigate your claim.E-mail address:vuresearchportal.ub@vu.nlDownload date: 27. May. 2021Incretin-based drugs and the kidney in type 2 diabetesmoving from safety to protection Lennart TonneijckIncretin-based drugs and the kidney in type 2 diabetesmoving from safety to protectionLennart TonneijckIncretin-based drugs and the kidney in type 2 diabetes

Incretin-based drugs and the kidney in type 2 diabetes:Moving from safety to protection

Abstract

Similar works

Full text

Available Versions

NARCIS

NARCIS

VU Research Portal